TRACON Pharmaceuticals (TCON) Financials

$0.03

$-0.01 (-25.98%)

As on 16-Jul-2025 16:00EDT

Market cap

$0 Mln

Revenue (TTM)

$3 Mln

P/E Ratio

0

P/B Ratio

11.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	3.20	12.05	9.00	0.35	0.35	--
Cost of Revenue	0.01	0.01	0.02	0.01	0.01	14.53
Gross Profit	3.19	12.03	-0.02	0.35	-0.01	-14.53
Operating Expenses	12.50	18.93	27.89	28.69	16.22	22.30
Operating Profit (EBIT)	-7.31	-6.90	-27.89	-28.35	-16.22	-22.30
Other Income	--	--	--	--	-0.01	0.01
Profit before Tax	5.20	-3.59	-29.14	-28.67	-16.78	-22.67
Provision for Tax	-2.41	-0.15	0.18	0.06	0.55	-0.02
Profit after Tax (Net Income)	5.20	-3.59	-29.31	-28.73	-17.33	-22.66
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-29.14	-28.67	-16.78	-22.67

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	-3.09	-0.81	-7.15	11.71	25.07	2.70
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.60	0.73	4.25	1.17	1.82	3.59
Current Liabilities	9.89	10.18	22.37	13.68	10.54	11.83
Total Liabilities	17.29	10.11	19.47	26.56	37.44	18.12

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	0.89	1.02	1.24	1.62	0.52	0.86
Current Assets	6.51	9.09	18.23	24.94	36.91	17.26
Total Assets	17.29	10.11	19.47	26.56	37.44	18.12
Total Debt*	--	0.97	9.81	1.39	4.53	5.34
Net Current Assets	-3.38	-1.09	-4.14	11.26	26.37	5.43

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	3.68	-26.24	-22.57	-17.04	-23.65
Cash Flow from Investing Activities	--	--	-0.02	3.95	-4.00	14.02
Cash from Financing Activities	--	-12.54	19.68	10.56	36.76	0.91
Net Cash Inflow / Outflow	--	--	--	--	15.72	-8.72

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	3.79	-1.78	-26.30	-29.55	-25.11	-143.41
Cash EPS ($)	--	-1.77	-26.23	-29.61	-25.13	-143.30
Adjusted Book Value ($)	--	--	--	12.05	36.34	17.08
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	1.83	-23.54	-23.22	-24.70	-149.68
Free Cash Flow per Share ($)	--	1.83	-23.55	-23.27	-24.71	-149.68

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-254.92	-371.96	-134.54	-92.06	-126.19
ROE (%)	--	90.15	-1,284.77	-156.18	-124.78	-187.72
ROA (%)	18.37	-24.26	-127.37	-89.78	-62.37	-77.11
EBIT Margin (%)	177.84	-57.27	-309.93	-8,192.77	-4,692.20	--
Net Margin (%)	162.34	-29.79	-325.69	-8,302.31	-5,110.91	-283,225.00
Cash Profit Margin (%)	0.01	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	-64.44	0.34	25.01	--	--	-1.00
EBIT Growth (%)	135.20	75.27	1.60	-74.60	27.18	35.82
Net Profit Growth (%)	118.22	87.76	-2.04	-65.80	23.53	35.19
EPS Growth (%)	116.33	0.93	0.11	-0.18	0.82	0.39
Book Value Growth (%)	89.96	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	0.01	-0.10	-0.06	-0.09	-0.47	-0.02
Price / Book Value	11.83	-0.43	-0.23	0.23	0.32	0.14
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.81	1.05	0.21	0.70	1.45	0.48
Close Price ($)	1.60	0.18	1.49	2.77	11.70	2.34
High Price ($)	3.37	2.19	3.05	12.20	11.85	17.30
Low Price ($)	0.13	0.13	1.10	2.18	0.95	2.07
Market Cap ($ Cr)	0.11	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	-1.20	-1.37	0.12	0.18	1.98
Short term debt to equity ratio	--	-0.29	-1.40	0.13	0.13	1.10
Current Ratio	0.66	0.89	0.81	1.82	3.50	1.46
Quick Ratio	0.66	--	--	--	--	--
Interest Coverage	7.41	-0.94	-28.06	-89.14	-29.79	-57.76

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	0.11	0.81	0.39	0.01	0.01	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	84,359.71	101,197.08	86,981.68	62,899.09	167.86
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.